These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 11997198

  • 1. Steady-state pharmacokinetic comparison of a new, extended-release, once-daily morphine formulation, Avinza, and a twice-daily controlled-release morphine formulation in patients with chronic moderate-to-severe pain.
    Portenoy RK, Sciberras A, Eliot L, Loewen G, Butler J, Devane J.
    J Pain Symptom Manage; 2002 Apr; 23(4):292-300. PubMed ID: 11997198
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics and pharmacodynamics of twenty-four-hourly Kapanol compared to twelve-hourly MS Contin in the treatment of severe cancer pain.
    Gourlay GK, Cherry DA, Onley MM, Tordoff SG, Conn DA, Hood GM, Plummer JL.
    Pain; 1997 Feb; 69(3):295-302. PubMed ID: 9085304
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetic evaluation of a sprinkle-dose regimen of a once-daily, extended-release morphine formulation.
    Eliot L, Butler J, Devane J, Loewen G.
    Clin Ther; 2002 Feb; 24(2):260-8. PubMed ID: 11911556
    [Abstract] [Full Text] [Related]

  • 4. Clinical efficacy and safety of once-daily dosing of a novel, prolonged-release oral morphine tablet compared with twice-daily dosing of a standard controlled-release morphine tablet in patients with cancer pain: a randomized, double-blind, exploratory crossover study.
    Ridgway D, Sopata M, Burneckis A, Jespersen L, Andersen C.
    J Pain Symptom Manage; 2010 Apr; 39(4):712-20. PubMed ID: 20413058
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of a once-daily morphine formulation in chronic, moderate-to-severe osteoarthritis pain: results from a randomized, placebo-controlled, double-blind trial and an open-label extension trial.
    Caldwell JR, Rapoport RJ, Davis JC, Offenberg HL, Marker HW, Roth SH, Yuan W, Eliot L, Babul N, Lynch PM.
    J Pain Symptom Manage; 2002 Apr; 23(4):278-91. PubMed ID: 11997197
    [Abstract] [Full Text] [Related]

  • 6. Sustained relief of chronic pain. Pharmacokinetics of sustained release morphine.
    Gourlay GK.
    Clin Pharmacokinet; 1998 Sep; 35(3):173-90. PubMed ID: 9784932
    [Abstract] [Full Text] [Related]

  • 7. A randomized, open-label study of once-a-day AVINZA (morphine sulfate extended-release capsules) versus twice-a-day OxyContin (oxycodone hydrochloride controlled-release tablets) for chronic low back pain: the extension phase of the ACTION trial.
    Rauck RL, Bookbinder SA, Bunker TR, Alftine CD, Ghalie R, Negro-Vilar A, de Jong E, Gershon S.
    J Opioid Manag; 2006 Sep; 2(6):325-8, 331-3. PubMed ID: 17326594
    [Abstract] [Full Text] [Related]

  • 8. Efficacy, safety, and steady-state pharmacokinetics of once-a-day controlled-release morphine (MS Contin XL) in cancer pain.
    Hagen NA, Thirlwell M, Eisenhoffer J, Quigley P, Harsanyi Z, Darke A.
    J Pain Symptom Manage; 2005 Jan; 29(1):80-90. PubMed ID: 15652441
    [Abstract] [Full Text] [Related]

  • 9. The ACTION study: a randomized, open-label, multicenter trial comparing once-a-day extended-release morphine sulfate capsules (AVINZA) to twice-a-day controlled-release oxycodone hydrochloride tablets (OxyContin) for the treatment of chronic, moderate to severe low back pain.
    Rauck RL, Bookbinder SA, Bunker TR, Alftine CD, Ghalie R, Negro-Vilar A, de Jong E, Gershon S.
    J Opioid Manag; 2006 Jan; 2(3):155-66. PubMed ID: 17319449
    [Abstract] [Full Text] [Related]

  • 10. Morphine sulfate extended-release capsules for the treatment of chronic, moderate-to-severe pain.
    Nicholson B.
    Expert Opin Pharmacother; 2008 Jun; 9(9):1585-94. PubMed ID: 18518787
    [Abstract] [Full Text] [Related]

  • 11. Randomized trial comparing polymer-coated extended-release morphine sulfate to controlled-release oxycodone HCl in moderate to severe nonmalignant pain.
    Nicholson B, Ross E, Sasaki J, Weil A.
    Curr Med Res Opin; 2006 Aug; 22(8):1503-14. PubMed ID: 16870075
    [Abstract] [Full Text] [Related]

  • 12. Assessment of analgesia in human chronic pain. Randomized double-blind crossover study of once daily repro-dose morphine versus MST continus.
    Peat S, Sweet P, Miah Y, Barklamb M, Larsen U.
    Eur J Clin Pharmacol; 1999 Oct; 55(8):577-81. PubMed ID: 10541775
    [Abstract] [Full Text] [Related]

  • 13. Factors affecting dosing regimens of morphine sulfate extended-release (KADIAN) capsules.
    Weil AJ, Nicholson B, Sasaki J.
    J Opioid Manag; 2009 Oct; 5(1):39-45. PubMed ID: 19344047
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetic profile of controlled-release carvedilol in patients with left ventricular dysfunction associated with chronic heart failure or after myocardial infarction.
    Packer M, Lukas MA, Tenero DM, Baidoo CA, Greenberg BH, 369 Study Group.
    Am J Cardiol; 2006 Oct 02; 98(7A):39L-45L. PubMed ID: 17023231
    [Abstract] [Full Text] [Related]

  • 15. Clinical pharmacokinetics of morphine and its metabolites during morphine dose titration for chronic cancer pain.
    De Gregori S, Minella CE, De Gregori M, Tinelli C, Ranzani GN, Govoni S, Allegri M, Regazzi M.
    Ther Drug Monit; 2014 Jun 02; 36(3):335-44. PubMed ID: 24595069
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and Safety of Once-Daily Extended-Release (ER) Hydrocodone in Individuals Previously Receiving ER Morphine for Chronic Pain.
    Broglio K, Pergolizzi J, Kowalski M, Lynch SY, He E, Wen W.
    Pain Pract; 2017 Mar 02; 17(3):382-391. PubMed ID: 27317188
    [Abstract] [Full Text] [Related]

  • 17. A randomized, open-label, multicenter trial comparing once-a-day AVINZA (morphine sulfate extended-release capsules) versus twice-a-day OxyContin (oxycodone hydrochloride controlled-release tablets) for the treatment of chronic, moderate to severe low back pain: improved physical functioning in the ACTION trial.
    Rauck RL, Bookbinder SA, Bunker TR, Alftine CD, Gershon S, de Jong E, Negro-Vilar A, Ghalie R.
    J Opioid Manag; 2007 Mar 02; 3(1):35-43. PubMed ID: 17367093
    [Abstract] [Full Text] [Related]

  • 18. Avinza - 24-h sustained-release oral morphine therapy.
    Caldwell JR.
    Expert Opin Pharmacother; 2004 Feb 02; 5(2):469-72. PubMed ID: 14996642
    [Abstract] [Full Text] [Related]

  • 19. Patient-controlled analgesia for mucositis pain in children: a three-period crossover study comparing morphine and hydromorphone.
    Collins JJ, Geake J, Grier HE, Houck CS, Thaler HT, Weinstein HJ, Twum-Danso NY, Berde CB.
    J Pediatr; 1996 Nov 02; 129(5):722-8. PubMed ID: 8917240
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.